https://www.taxtmi.com/caselaws?id=73195 Analgin tablets covered by the Indian Pharmacopoeia and the National Formulary of India were treated as pharmacopoeial preparations because the notified editions of those publications applied and the tablets fell within the prescribed dosage range. The mere presence of the manufacturer's name, symbol or monogram on the carton did not, by itself, make the product a patent or proprietary medicine; proprietary character required a trade connection shown by the marking. The rule-compliance objection also failed because the recognised pharmacopoeial abbreviation appeared on the carton. On that basis, classification under Tariff Item 14E was not justified. en-us Fri, 17 Jul 1987 00:00:00 +0530 Mon, 30 May 2011 12:07:13 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=73195 Analgin tablets covered by the Indian Pharmacopoeia and the National Formulary of India were treated as pharmacopoeial preparations because the notified editions of those publications applied and the tablets fell within the prescribed dosage range. The mere presence of the manufacturer's name, symbol or monogram on the carton did not, by itself, make the product a patent or proprietary medicine; proprietary character required a trade connection shown by the marking. The rule-compliance objection also failed because the recognised pharmacopoeial abbreviation appeared on the carton. On that basis, classification under Tariff Item 14E was not justified. Case-Laws Central Excise Fri, 17 Jul 1987 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=73195